[1] Ramchand J, Fava AM, Chetrit M, et al.Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy[J]. Heart. 2020;106(11):793-801.[2] Files Flores R, Mané F, Antunes N, et al. Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report[J]. Eur Heart J CaseRep. 2020;4(5):1-4. Published 2020 Oct.[3] Ito T, Suwa M. Echocardiographic tissue imaging evaluation of myocardial characteristics and function in cardiomyopathies[J]. Heart Fail Rev. 2021;26(4):813-828.[4] Lewicka-Potocka Z, Dąbrowska-Kugacka A, Lewicka E, et al. The “athlete’s heart” features in amateur male marathon runners[J]. Cardiol J. 2021;28(5):707-715.[5] 李志明, 韩丹, 杞天付, 等. 心脏磁共振T1mapping 技术评估肥厚型心肌病心肌纤维化[J]. 中国医学影像学杂志, 2022,30(4):341-347.[6] 姚岗, 卢嘉翰, 张强. 心脏MR T1 mapping 技术对肥厚型心肌病心肌纤维化的诊断价值[J]. 川北医学院学报, 2023,38(9):1232-1235.[7] Li Y, Liu X, Yang F, et al. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and shortin hypertrophic cardiomyopathy[J]. Eur Radiol. 2021;31(7):4557-4567.[8] 梁学恒, 高世平, 石思玮. 心脏MR T1 mapping 技术在肥厚型心肌病与高血压性心脏病的诊断价值[J]. 实用放射学杂志, 2023,39(4):566-570.[9] Shi RY, Wu R, An DL, et al. Texture analysis applied in T1 maps and extracellular volume obtained using cardiac MRI in the diagnosis of hypertrophic cardiomyopathyand hypertensive heart disease compared with normal controls[J]. Clin Radiol. 2021;76(3):236.e9-236.e19.[10] Greulich S, Seitz A, Herter D, et al. Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study[J]. Eur HeartJ Cardiovasc Imaging. 2021;22(7):732-741.[11] Yang Y, Yin G, Jiang Y, et al. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonancefeature tracking imaging: a feasibility and reproducibility study[J]. J Cardiovasc Magn Reson. 2020;22(1):1.[12] Śpiewak M, Kłopotowski M, Mazurkiewicz Ł, et al. Predictors of right ventricular function and size in patients with hypertrophic cardiomyopathy[J]. SciRep. 2020;10(1):21054.[13] 李雪菲, 焦凤辉, 王桂东, 等. 心脏磁共振成像在HCM 诊断及预后评估中的应用[J]. 中国CT 和MRI 杂志, 2025,23(1):89-91.[14] 苏瑾, 朱永胜, 罗秀霞, 等. 心脏磁共振和超声诊断肥厚性心肌病的价值[J]. 影像诊断与介入放射学, 2020,29(3):167-170.[15] Grant MD, Mann RD, Kristenson SD, et al. Transthoracic Echocardiography: Beginner’s Guide with Emphasis on Blind Spots as Identified with CT and MRI[J].Radiographics. 2021 Jul-Aug;41(4):1022-1042.[16] 王晓琰, 肖华, 郭久红, 等. 磁共振成像在心尖肥厚型心肌病中的诊断价值[J]. 分子影像学杂志, 2019,42(1):1-4.[17] 卢拥华, 徐细平, 曾知恒. 心肌致密化不全的诊断与鉴别诊断[J]. 右江民族医学院学报, 2010,32(6):853-855.[18] Li X, Shi K, Yang ZG, et al. Assessing right ventricular deformation in hypertrophic cardiomyopathy patients with preserved right ventricular ejection fraction: a 3.0-Tcardiovascular magnetic resonance study[J]. Sci Rep. 2020;10(1):1967.[19] Ding W, Bhushan S, Ma C, et al. Right Ventricle Involvement in Hypertrophic Cardiomyopathy and Role of Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy:Review Article[J]. Heart Surg Forum. 2021;24(4):E746-E750.[20] 于建才, 刘永兴, 袁永刚, 等. 心脏磁共振诊断梗阻性肥厚型心肌病1 例[J]. 医学影像学杂志, 2019,29(4):536,552.[21] 和燕斐, 葛红, 杨瑞, 等. 心脏磁共振对梗阻性肥厚型心肌病化学消融术后的随访价值[J]. 河南医学高等专科学校学报, 2022,34(4):416-420.[22] Palmisano V, Cossa S, Esposito A, et al. Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: Differences in Global and Segmental Myocardial Strain byCardiac Magnetic Resonance Feature Tracking[J]. J Thorac Imaging. 2022;37(1):49-57.[23] Farrag NA, Lochbihler A, White JA, et al.Evaluation of fully automated myocardial segmentation techniques in native and contrast-enhanced T1-mapping cardiovascularmagnetic resonance images using fully convolutional neural networks[J]. Med Phys. 2021;48(1):215-226.[24] Vanmali A, Alhumaid W, White JA. Cardiovascular Magnetic Resonance-Based Tissue Characterization in Patients With Hypertrophic Cardiomyopathy[J]. Can J Cardiol.2024;40(5):887-898.[25] Rowin EJ, Schulz A. Role of cardiac magnetic resonance imaging in the management of hypertrophic cardiomyopathy[J]. Indian J Thorac Cardiovasc Surg. 2026;42(2):168-180.[26] Nakamori S, Rowin EJ, Rodriguez J, et al. Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy[J]. J Cardiovasc MagnReson. 2024;26(2):101072.[27] Markousis-Mavrogenis G, Giannakopoulou A, Belegrinos A, et al. Cardiovascular Magnetic Resonance Imaging Patterns in Rare Cardiovascular Diseases[J]. J Clin Med.2022;11(21).临床研究 | CLINICAL RESEARCH050 | Copyright © This Work is Licensed under A Commons Attribution-Non Commercial 4.0 International License.[28] Yang Z, Yao FY, Long YT, et al. Association between cardiac dysfunction and late gadolinium enhancement confined to the LV intramural region in patients withhypertrophic cardiomyopathy[J]. Ann Med. 2025;57(1):2533425.[29] Zhi Y, Zhang TY, Gui FD, et al. Myocardial Fibrosis Evaluated by T1 Mapping and Its Relationship to Left Ventricular Hypertrophy, Strain, and T2 Value inHypertrophic Cardiomyopathy Without Late Gadolinium Enhancement[J]. J Thorac Imaging. . Published online Oct 14,2025. doi:10.1097/RTI.0000000000000862.[30] Mancio J, Pashakhanloo F, El-Rewaidy H, et al. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy[J]. Eur Heart JCardiovasc Imaging. 2022;23(4):532-542.[31] Fahmy AS, Rowin EJ, Arafati A, et al. Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy[J]. J Cardiovasc Magn Reson.2022;24(1):40.[32] Huang S, Shi K, Zhang Y, et al. Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis andhypertrophic cardiomyopathy[J]. BMC Cardiovasc Disord. 2022;22(1):235.[33] 官乐, 林辉, 赵振华, 等. 心脏磁共振影像组学对肥厚性心肌病的诊断和预测价值[J]. 全科医学临床与教育, 2024,22(3):256-259.[34] Zhang H, Tian J, Zhang C, et al. Discrimination models with radiomics features derived from cardiovascular magnetic resonance images for distinguishing hypertensiveheart disease from hypertrophic cardiomyopathy[J]. Cardiovasc Diagn Ther. 2024;14(1):129-142.[35] Zhou H, Li L, Liu Z, et al. Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images[J]. Eur Radiol.2021;31(6):3931-3940.[36] Sahota M, Saraskani SR, Xu H, et al. Machine learning evaluation of LV outflow obstruction in hypertrophic cardiomyopathy using three-chamber cardiovascularmagnetic resonance[J]. Int J Cardiovasc Imaging. 2022;38(12):2695-2705.[37] Kim EK, Lee SC, Chang SA, et al. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect inhypertrophic cardiomyopathy[J]. J Cardiovasc Magn Reson. 2020;22(1):30.[38] 喻诗琴, 杨凯, 赵世华. 单纯心尖肥厚型心肌病进展为中部梗阻并室壁瘤形成1 例[J]. 中华心血管病杂志[J], 2024,52(1):79-81.[39] Sharka I, Panichella G, Grigoratos C, et al. Myocardial Perfusion Imaging with Cardiovascular Magnetic Resonance in Nonischemic Cardiomyopathies: An In-DepthReview of Techniques and Clinical Applications[J]. Medicina (Kaunas). 2025;61(5).[40] Ku MC, Kober F, Lai YC, et al. Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy[J]. J CardiovascMagn Reson. 2021;23(1):63.[41] Tanigaki T, Kato S, Azuma M, Ito M, Horita N, Utsunomiya D. Coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance imaging ofcoronary sinus: a meta-analysis[J]. J Cardiovasc Magn Reson. 2023;25(1):11.[42] Schulz A, Wallace TE, Chow K, et al. Quantitative myocardial blood flow and perfusion reserve with exercise cardiovascular magnetic resonance[J]. J Cardiovasc MagnReson. 2025 Winter;27(2):101988.[43] Huurman R, van der Velde N, Schinkel AFL, et al. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance[J]. EurHeart J Cardiovasc Imaging. 2022;23(9):1144-1154.[44] Joy G, Lopes LR, Webber M, et al. Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-GuidedElectrocardiography[J]. J Am Coll Cardiol. 2024;83(11):1042-1055.[45] 李元程, 王杰, 陈玉成. 肥厚型心肌病基因型与磁共振表型的关联性研究进展[J]. 心血管病学进展, 2019,40(2):157-161.